Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion evidence source_evidence_literature NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion SIO_000772 25504634 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion wasDerivedFrom befree-2016 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion wasGeneratedBy ECO_0000203 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- befree-2016 importedOn "2016-02-19" NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.